Search research articles
Contact Us
Filters
Showing results (81-90 of 141) with videos related to
Page
of 15
Sort By:
BMJ Open
|
August 1, 2014
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial
Helen A Dakin, Sarah Wordsworth, Chris A Rogers, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 6, 2022
The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis
Heleen Vellekoop, Matthijs Versteegh, Simone Huygens, et al.
Applied Health Economics and Health Policy
|
January 20, 2025
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework
Hadley Stevens Smith, Dean A Regier, Ilias Goranitis, et al.
JAMA Network Open
|
July 10, 2024
Health Care Costs After Genome-Wide Sequencing for Children With Rare Diseases in England and Canada
Deirdre Weymann, John Buckell, Patrick Fahr, et al.
Cancer Epidemiology
|
May 19, 2019
Risk attitudes and sun protection behaviour: Can behaviour be altered by using a melanoma genomic risk intervention?
Rachael L Morton, Rebecca Asher, Edward Peyton, et al.
Seminars in Cancer Biology
|
June 27, 2021
Clinical utility of whole-genome sequencing in precision oncology
Richard Rosenquist, Edwin Cuppen, Reinhard Buettner, et al.
BMJ Open
|
July 13, 2016
Effectiveness of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual non-inferiority trial
Barnaby C Reeves, Lauren J Scott, Jodi Taylor, et al.
Applied Health Economics and Health Policy
|
March 8, 2021
Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom
James Buchanan, Laurence S J Roope, Liz Morrell, et al.
Lancet (London, England)
|
December 9, 2023
Population screening requires robust evidence-genomics is no exception
Clare Turnbull, Helen V Firth, Andrew O M Wilkie, et al.
Personalized Medicine
|
September 11, 2023
Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young
Gábor Kovács, Dávid Nagy, László Szilberhorn, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 141) with videos related to
Sort By:
Page
of 15
BMJ Open
|
August 1, 2014
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial
Helen A Dakin, Sarah Wordsworth, Chris A Rogers, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 6, 2022
The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis
Heleen Vellekoop, Matthijs Versteegh, Simone Huygens, et al.
Applied Health Economics and Health Policy
|
January 20, 2025
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework
Hadley Stevens Smith, Dean A Regier, Ilias Goranitis, et al.
JAMA Network Open
|
July 10, 2024
Health Care Costs After Genome-Wide Sequencing for Children With Rare Diseases in England and Canada
Deirdre Weymann, John Buckell, Patrick Fahr, et al.
Cancer Epidemiology
|
May 19, 2019
Risk attitudes and sun protection behaviour: Can behaviour be altered by using a melanoma genomic risk intervention?
Rachael L Morton, Rebecca Asher, Edward Peyton, et al.
Seminars in Cancer Biology
|
June 27, 2021
Clinical utility of whole-genome sequencing in precision oncology
Richard Rosenquist, Edwin Cuppen, Reinhard Buettner, et al.
BMJ Open
|
July 13, 2016
Effectiveness of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual non-inferiority trial
Barnaby C Reeves, Lauren J Scott, Jodi Taylor, et al.
Applied Health Economics and Health Policy
|
March 8, 2021
Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom
James Buchanan, Laurence S J Roope, Liz Morrell, et al.
Lancet (London, England)
|
December 9, 2023
Population screening requires robust evidence-genomics is no exception
Clare Turnbull, Helen V Firth, Andrew O M Wilkie, et al.
Personalized Medicine
|
September 11, 2023
Cost-effectiveness of genetic-based screening strategies for maturity-onset diabetes of the young
Gábor Kovács, Dávid Nagy, László Szilberhorn, et al.
Page
of 15